Apr 2 |
Q4 2023 Omeros Corp Earnings Call
|
Apr 2 |
Omeros Corporation (NASDAQ:OMER) Q4 2023 Earnings Call Transcript
|
Apr 2 |
Omeros Corporation (OMER) Q4 2023 Earnings Call Transcript
|
Apr 1 |
Omeros Corp (OMER) Reports Fourth Quarter and Year-End 2023 Financial Results
|
Apr 1 |
Omeros GAAP EPS of -$0.63 misses by $0.07
|
Apr 1 |
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
|
Apr 1 |
Earnings Scheduled For April 1, 2024
|
Mar 31 |
Omeros Q4 2023 Earnings Preview
|
Mar 27 |
Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
|
Feb 20 |
Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
|